Search results
Results from the WOW.Com Content Network
Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in San Francisco, CA, developing proprietary therapeutics primarily for treating central nervous system ("CNS") disorders. In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceeds. [ 3 ]
Endo is one of the companies named in lawsuits by the states of Ohio, [42] Missouri and Mississippi [43] as responsible for the US opioid epidemic. Its 10-K statement indicates that a majority of the company's US revenue in 2016 was derived from the sale of prescription pain killers, predominantly opioids. [44]
This is the list of Schedule II controlled substances in the United States as defined by the ... opiate Codeine [2] 9334 opiate Dihydroetorphine [3] 9190 opiate ...
Last year, California signed a 10-year agreement with the nonprofit Civica to produce CalRx branded insulin, which is used to treat diabetes. California has set aside $100 million for that project, with $50 million to develop the drugs and the rest set aside to invest in a manufacturing facility. Newsom said a 10 milliliter vial of state ...
McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive ...
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the drug that can save someone's life during an opioid overdose, under a deal ...
California will provide first responders, universities and other qualifying organizations with a generic version of Narcan, the opioid overdose reversal drug, for free, Gov. Gavin Newsom announced ...
The university also began an "Opioid Stewardship Committee" to "…consistently and frequently address opioid stewardship." [3] Opioid data for Alabama indicated that, from 2006 to 2014 2.3 billion pain pills were prescribed in the state. McKesson Corporation distributed 728 million of these pain pills; Par Pharmaceutical manufactured 713 million.